How to invest in an environment of rising inflation and unpredictable central bank policy
This week central banker Lael Brainard - a long-term dove - rattled markets by suggesting America's Federal Reserve will unwind quantitative easing faster than expected. John Stepek explains what is going on.


A central banker gave investors a nasty wake-up call this week. It wasn’t one of the usual suspects – Federal Reserve chairman Jerome Powell, or Bank of England boss Andrew Bailey. It was Lael Brainard, who is set to take over as vice-chair of the Fed.
On Tuesday, she warned that quantitative tightening (QT – the process by which the Fed sells the bonds it bought under quantitative easing) will start earlier and be more aggressive than investors had hoped.
Why is this significant? Because when Brainard was nominated to take the vice-chair role by US president Joe Biden late last year, she was widely viewed as a “dove” who would err on the side of loose monetary policy, and had occasionally nodded towards the ideas of modern monetary theory (MMT – funding public spending via unlimited money printing). So much for that.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Markets are starting to wake up
Before you start imagining that we’re heading for a repeat of the early 1980s, with the Fed pushing interest rates well into double-digit levels to crush inflationary pressure, it’s worth noting that central bank resolve has yet to be tested by the market.
The particularly grim tone of news headlines right now, along with attention-grabbing volatility in oil markets, has obscured this fact, but the reality is that most global stockmarkets simply haven’t done that badly this year.
For example, from its most recent high at the start of 2022, to its most recent low in mid-March, the S&P 500 fell by around 13%. That’s a “correction” (down more than 10%), but not a “bear” market (down more than 20%). And since then, it’s rebounded by about 7%, meaning it’s only down around 7% for the year to date.
That might be painful for investors who have been conditioned to “buy the dip”, but it’s hardly a big fall. In the context of a major war in Europe, high and rising consumer price inflation, and even rising interest rates, some might argue that it is positively miraculous.
Of course, this sudden urgency to tackle inflation does rather imply that central banks are already too late. One sign that markets are now taking inflation seriously is that while bond prices have slid (and yields have risen, as a result) gold has performed well.
In recent years, higher bond yields have meant falling gold prices (gold pays no interest, so if bond yields rise, they should become more appealing in relative terms). Yet they have now “decoupled”. As Louis-Vincent Gave of Gavekal points out, “the fixed-income market and the gold market are sending the same message: deflation is no longer the main threat for portfolios”.
Novelty is out of fashion
So investors have to contend not just with rising inflation, but also with a less predictable Fed. That’s not an easy environment to invest in. So stick to tried and tested principles: buy cheap and buy stuff you understand. Novelty is out, and old-fashioned investing is back.
For example, on page 28 John Chambers looks at how technology hasn’t proved to be a magic bullet for the insurance sector as some had hoped, and recommends some rather more traditional Lloyd’s of London insurers instead.
Meanwhile, speaking of gold, on page 18 Dominic looks at why gold-mining stocks have done so poorly relative to gold. More importantly, he wonders if that might change soon, and how you might profit.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
What makes you wealthy in the UK? Could it make you a target in Rachel Reeves’ Budget?
Wealthy Brits could be at risk from a Budget tax raid – but how much money do you need to be considered wealthy in the UK?
-
More retirees are buying inflation-protected annuities. What are they and how do they work?
Sales of annuities where the income on offer increases every year have surged – and more people are also taking up enhanced rates that are higher due to illness
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
The Palace of Westminster is falling down
The Palace of Westminster is in need of repair, but the bill is prohibitive, says Simon Wilson
-
'Gen Z is facing an AI jobs bloodbath'
Opinion It has always been tough to get your first job, but this year, it's proving tougher than ever. AI is to blame, says Matthew Lynn
-
Should the Online Safety Act survive?
The Online Safety Act, a measure to safeguard children, is having unintended consequences
-
The secret behind Sweden’s success
Opinion Sweden's stock market is in rude health, says Max King. Why can't Britain follow suit?
-
Prabowo Subianto: Indonesia’s Deng Xiaoping
Prabowo Subianto, like his Chinese hero, is taking power in his 70s with big ambitions for his country. Yet many view his return to politics with dread